All Articles

Heartland Dental CEO Pat Bauer's Titan Award celebrates his 'doctor-led' vision. But what does this mean for an industry increasingly shaped by private equity?

Cresco Labs posts a 15% revenue jump, touting operational wins ahead of federal reform. But a surprise CFO departure introduces a new variable.

Opal Therapeutics' organoid platform, backed by a major NSF award, bypasses failed animal models to fast-track cures for endometriosis and fibroids.

Lamar's stellar Q2 results, beating forecasts on all key metrics, signal robust health in the outdoor ad market and highlight its digital strategy's success.

Arhaus reported record profits, but a one-time tariff refund tells only half the story. We dig into the numbers to find the real drivers of future growth.

A landmark deal injects C$31M into Copper Giant’s Mocoa project, securing a path to market and positioning Colombia as a key player in the energy transition.

Enerflex's Q2 results reveal a masterclass in strategy. With a record backlog and fortified balance sheet, the firm is shedding assets to fund its future.

Paramount Resources posts a blowout quarter with record-setting Montney wells, raising production guidance while holding spending flat—a feat of capital efficiency.

Evolent Health touts soaring revenues and a major oncology deal, yet falling profits and rising medical costs reveal a challenging road ahead. Can AI deliver the efficiency it needs?

Greenland Energy is scaling back its winter drilling plan. It's not a retreat, but a strategic signal of caution in a high-stakes Arctic balancing act.

Cross-Border Impact Ventures secures a $58M first close for its second fund, targeting the vastly underserved but rapidly growing women's and children's health market.

Mastech Digital's Q2 results reveal a tale of two segments. While its AI division shows its first growth since 2024, the legacy staffing unit struggles.

Dana Inc. flexes its operational muscle with stellar Q2 results and a revived buyback, all while the game-changing Eaton Mobility merger looms on the horizon.

Milton and Feeding India's partnership to deliver 25,000 steel tiffins is more than charity; it's a blueprint for aligning corporate assets with social good.

As flight disruptions surge, a niche travel firm bets its future not on cutting prices, but on providing the human support that giant online portals lack.

Grist Mill Exchange and Ocient partner to slash data integration times from months to seconds, giving defense and intelligence agencies real-time decision advantage.

Beyond the tiger trail, one company is rewriting the rules of wildlife tourism. Pugdundee Safaris' 2028 carbon-neutral goal is more than a promise—it's a business model.

Pony.ai's aggressive push into autonomous trucking isn't just about tech. It’s a systemic overhaul of logistics, enabled by falling costs and new rules.

A new report from broker JustMarkets reignites the conversation on USD strength. We explore the deep forces driving the dollar and its cascading global impact.

Actimed Therapeutics reclaims S-oxprenolol, a promising ALS drug. This isn't just a pipeline shuffle; it's a calculated move to dominate the future of muscle health.